These Analysts Revise Their Forecasts On Estee Lauder After Q4 Earnings

Estée Lauder (EL) reported Q4 adjusted EPS in-line and sales slightly above consensus, despite a 12% year-over-year decline. The key takeaway is the company's robust fiscal 2026 outlook, projecting EPS of $1.90-$2.10 and sales of $14.613-$15.042 billion, both significantly exceeding analyst consensus, signaling management's confidence in returning to organic sales growth and rebuilding profitability after three years of declines, despite an anticipated $100 million tariff headwind. Shares rose 1.7% on the news, with analysts largely maintaining positive ratings despite mixed price target adjustments.

Analysis

Estée Lauder reported mixed fourth-quarter results, with an in-line adjusted EPS of $0.09 and a 12% year-over-year decline in quarterly sales to $3.41 billion, which nonetheless slightly exceeded consensus estimates. The primary driver for the positive market reaction was the company's robust financial outlook for fiscal year 2026. Management projects an EPS range of $1.90 to $2.10, significantly surpassing the analyst consensus of $1.48, while forecasting sales between $14.613 billion and $15.042 billion, also above expectations. This guidance signals management's confidence in reversing a three-year trend of declining sales and restoring operating profitability towards a solid double-digit margin, even while factoring in an anticipated $100 million headwind from tariffs. In response, EL shares rose 1.7%, and while analysts at RBC and JP Morgan maintained positive ratings, their price target adjustments were divergent, indicating nuanced views on valuation despite the optimistic outlook.

Key Decisions for Investors

• Investors should weigh the strong forward-looking fiscal 2026 guidance, which suggests a significant operational turnaround, against the weak trailing performance exemplified by the 12% year-over-year sales decline.
• Given the ambitious targets for growth and margin recovery after three years of declines, it is critical to monitor the company's execution on its strategic initiatives in subsequent quarters.
• The divergence in analyst price targets, despite consistently positive ratings, suggests that while the turnaround story is compelling, there is uncertainty regarding the stock's ultimate valuation, warranting consideration of position sizing and risk.